{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:52:35Z","timestamp":1792000355613,"version":"4.4.0"},"reference-count":24,"publisher":"Pacini Editore","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Otorhinolaryngol Ital"],"DOI":"10.14639\/0392-100x-n1392","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T09:12:11Z","timestamp":1636017131000},"page":"481-486","source":"Crossref","is-referenced-by-count":5,"title":["Inhibitory effect of mesna and 5-fluorouracil on propylene glycol-induced cholesteatoma in rats","Gli effetti inibitori del mesna e 5-fluorouracile nel colesteatoma indotto dal glicol-propilene nei topi"],"prefix":"10.14639","volume":"41","author":[{"given":"Numan","family":"Kokten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozan","family":"Tuysuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulay","family":"Zenginkinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih Mehmet","family":"Hanege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut Tayyar","family":"Kalcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"20340","published-online":{"date-parts":[[2021,10]]},"reference":[{"key":"10.14639\/0392-100X-N1392_ref1","doi-asserted-by":"crossref","unstructured":"Yung M, Tono T, Olszewska E, et al. EAONO\/JOS Joint Consensus Statements on the definitions, classification and staging of middle ear cholesteatoma. J Int Adv Otol 2017;13:1-8. https:\/\/doi.org\/10.5152\/iao.2017.3363","DOI":"10.5152\/iao.2017.3363"},{"key":"10.14639\/0392-100X-N1392_ref2","doi-asserted-by":"crossref","unstructured":"Kalcioglu MT, Cicek MT, Bayindir T, et al. Effectiveness of MESNA on the success of cholesteatoma surgery. Am J Otolaryngol 2014;35:357-361. https:\/\/doi.org\/10.1016\/j.amjoto.2014.01.002","DOI":"10.1016\/j.amjoto.2014.01.002"},{"key":"10.14639\/0392-100X-N1392_ref3","doi-asserted-by":"crossref","unstructured":"De la Torre C, Villamor P. Chemically assisted dissection with sodium 2-mercaptoethanesulfonate (MESNA) in the surgical management of pediatric cholesteatoma. Otol Neurotol 2019;40:645-650. https:\/\/doi.org\/10.1097\/MAO.0000000000002174.","DOI":"10.1097\/MAO.0000000000002174"},{"key":"10.14639\/0392-100X-N1392_ref4","doi-asserted-by":"crossref","unstructured":"Ismi O, Karabulut YY, Bal KK, et al. Single dose intratympanic mesna application inhibits propylene glycol induced cholesteatoma formation. Laryngol Otol 2017;131:215-220. https:\/\/doi.org\/10.1017\/S002221511600983X.","DOI":"10.1017\/S002221511600983X"},{"key":"10.14639\/0392-100X-N1392_ref5","doi-asserted-by":"crossref","unstructured":"Takahashi H, Funabiki K, Hasebe S, et al. Clinical efficacy of 5-fluorouracil (5-FU) topical cream for treatment of cholesteatoma. Auris Nasus Larynx 2005;32:353-357. https:\/\/doi.org\/10.1016\/j.anl.2005.05.015","DOI":"10.1016\/j.anl.2005.05.015"},{"key":"10.14639\/0392-100X-N1392_ref6","doi-asserted-by":"crossref","unstructured":"Yilmaz M, Goksu N, Bayramoglu I, et al. Practical use of MESNA in atelectatic ears and adhesive otitis media. ORL J Otorhinolaryngol Relat Spec 2006;68:195-198. https:\/\/doi.org\/10.1159\/000091472","DOI":"10.1159\/000091472"},{"key":"10.14639\/0392-100X-N1392_ref7","doi-asserted-by":"crossref","unstructured":"E\u011filmez OK, K\u00f6kten N, Baran M, et al. Electrophysiological and histopathological evaluation of effects of sodium-2 mercaptoethanesulfonate used for middle ear surgery on facial nerve functions. J Int Adv Otol 2018;14:239-244. https:\/\/doi.org\/10.5152\/iao.2017.3888","DOI":"10.5152\/iao.2017.3888"},{"key":"10.14639\/0392-100X-N1392_ref8","doi-asserted-by":"crossref","unstructured":"Vincenti V, Mondain M, Pasanisi E, et al. Cochlear effects of mesna application into the middle ear. Ann N Y Acad Sci 1999;884:425-432. https:\/\/doi.org\/10.1111\/j.1749-6632.1999.tb08659.x","DOI":"10.1111\/j.1749-6632.1999.tb08659.x"},{"key":"10.14639\/0392-100X-N1392_ref9","doi-asserted-by":"crossref","unstructured":"Van Spaendonck MP, Timmermans JP, Claes J, et al. Single ototopical application of mesna has no ototoxic effects on guinea pig cochlear hair cells: a morphological study. Acta Otolaryngol 1999;119:685-689. https:\/\/doi.org\/10.1080\/00016489950180630","DOI":"10.1080\/00016489950180630"},{"key":"10.14639\/0392-100X-N1392_ref10","doi-asserted-by":"crossref","unstructured":"Eren SB, Dogan R, Vural \u00d6, et al. Use of mesna in the treatment of ossicular chain fixation related to tympanosclerosis; prospective, clinical study. Am J Otolaryngol 2020;41:102506. https:\/\/doi.org\/10.1016\/j.amjoto.2020.102506","DOI":"10.1016\/j.amjoto.2020.102506"},{"key":"10.14639\/0392-100X-N1392_ref11","doi-asserted-by":"crossref","unstructured":"Wright CG, Bird LL, Meyerhoff WL. Effect of 5-fluorouracil in cholesteatoma development in an animal model. Am J Otolaryngol 1991;12:133-138. https:\/\/doi.org\/10.1016\/0196-0709(91)90142-3","DOI":"10.1016\/0196-0709(91)90142-3"},{"key":"10.14639\/0392-100X-N1392_ref12","doi-asserted-by":"crossref","unstructured":"Kanemaru S, Nakamura T, Yamashita M, et al. 5-fluorouracil ointment for the treatment of otitis media with effusion. Laryngoscope 2007;117:215-219. https:\/\/doi.org\/10.1097\/01.mlg.0000248231.62834.e3","DOI":"10.1097\/01.mlg.0000248231.62834.e3"},{"key":"10.14639\/0392-100X-N1392_ref13","doi-asserted-by":"crossref","unstructured":"Antunes ML, Fukuda Y, Penido Nde O, et al. Effect of trans-retinoic acid in the inhibition of cholesteatoma in guinea pigs. Braz J Otorhinolaryngol 2008;74:53-60. https:\/\/doi.org\/10.1016\/s1808-8694(15)30751-5","DOI":"10.1016\/S1808-8694(15)30751-5"},{"key":"10.14639\/0392-100X-N1392_ref14","doi-asserted-by":"crossref","unstructured":"Sennaroglu L, Ozkul A, Gedikoglu G, et al. Effect of intratympanic steroid application on the development of experimental cholesteatoma. Laryngoscope 1998;108:543-547. https:\/\/doi.org\/10.1097\/00005537-199804000-00015","DOI":"10.1097\/00005537-199804000-00015"},{"key":"10.14639\/0392-100X-N1392_ref15","doi-asserted-by":"crossref","unstructured":"Melo AA, Caldas Neto SS, Le\u00e3o FS, et al. Effect of intratympanic mitomycin C on the development of cholesteatoma and otitis media in rats. J Laryngol Otol 2013;127:359-363. https:\/\/doi.org\/10.1017\/S002221511300011X","DOI":"10.1017\/S002221511300011X"},{"key":"10.14639\/0392-100X-N1392_ref16","doi-asserted-by":"crossref","unstructured":"White SJ, Wright CG, Robinson KS, et al. Effect of topical hyaluronic acid on experimental cholesteatoma. Am J Otolaryngol 1995;16:312-318. https:\/\/doi.org\/10.1016\/0196-0709(95)90059-4","DOI":"10.1016\/0196-0709(95)90059-4"},{"key":"10.14639\/0392-100X-N1392_ref17","unstructured":"Kayhan FT, Alg\u00fcn Z. The effect of naproxen sodium on experimental otitis media. Kulak Burun Bogaz Ihtis Derg 2008;18:14-18."},{"key":"10.14639\/0392-100X-N1392_ref18","doi-asserted-by":"crossref","unstructured":"Pownell PH, Wright CG, Robinson KS, et al. The effect of cyclophosphamide on development of experimental cholesteatoma. Arch Otolaryngol Head Neck Surg 1994;120:1114-1116. https:\/\/doi.org\/10.1001\/archotol.1994.01880340058009","DOI":"10.1001\/archotol.1994.01880340058009"},{"key":"10.14639\/0392-100X-N1392_ref19","doi-asserted-by":"crossref","unstructured":"Jove MA, Vassalli L, Raslan W, et al. The effect of isotretinoin on propylene glycol-induced cholesteatoma in chinchilla middle ears. Am J Otolaryngol 1990;11:5-9. https:\/\/doi.org\/10.1016\/0196-0709(90)90163-p","DOI":"10.1016\/0196-0709(90)90163-P"},{"key":"10.14639\/0392-100X-N1392_ref20","unstructured":"Kayhan FT, Alg\u00fcn Z. The effect of systemic prednisolone on propylene glycol-induced otitis media in guinea pig. Kulak Burun Bogaz Ihtis Derg 2006;16:214-220."},{"key":"10.14639\/0392-100X-N1392_ref21","doi-asserted-by":"crossref","unstructured":"Vassalli L, Harris DM, Gradini R, et al. Inflammatory effects of topical antibiotic suspensions containing propylene glycol in chinchilla middle ears. Am J Otolaryngol 1988;9:1-5. https:\/\/doi.org\/10.1016\/s0196-0709(88)80001-2","DOI":"10.1016\/S0196-0709(88)80001-2"},{"key":"10.14639\/0392-100X-N1392_ref22","doi-asserted-by":"crossref","unstructured":"Smith MF. The topical use of 5-fluorouracil in the ear in the management of cholesteatoma and excessive mucous secretion. Laryngoscope 1985;95:1202-1203. https:\/\/doi.org\/10.1288\/00005537-198510000-00010","DOI":"10.1288\/00005537-198510000-00010"},{"key":"10.14639\/0392-100X-N1392_ref23","doi-asserted-by":"crossref","unstructured":"Takahashi H, Funabiki K, Hasebe S, et al. Clinical efficacy of 5-fluorouracil (5-FU) topical cream for treatment of cholesteatoma. Auris Nasus Larynx 2005;32:353-357. https:\/\/doi.org\/10.1016\/j.anl.2005.05.01","DOI":"10.1016\/j.anl.2005.05.015"},{"key":"10.14639\/0392-100X-N1392_ref24","doi-asserted-by":"crossref","unstructured":"Yamamoto-Fukuda T, Terakado M, Hishikawa Y, et al. Topical application of 5-fluorouracil on attic cholesteatoma results in downregulation of keratinocyte growth factor and reduction of proliferative activity. Eur Arch Otorhinolaryngol 2008;265:1173-1178. https:\/\/doi.org\/10.1007\/s00405-008-0597-9","DOI":"10.1007\/s00405-008-0597-9"}],"container-title":["Acta Otorhinolaryngologica Italica"],"original-title":[],"link":[{"URL":"https:\/\/www.actaitalica.it\/article\/view\/1392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T07:18:38Z","timestamp":1729667918000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.actaitalica.it\/article\/view\/1392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,10]]}},"URL":"https:\/\/doi.org\/10.14639\/0392-100x-n1392","relation":{},"ISSN":["1827-675X"],"issn-type":[{"value":"1827-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]},"article-number":"13"}}